Enzyme: everything you need to know about MLN

What is Enzyme?

Enzyme is a decentralized open-source trading protocol built on the Ethereum blockchain. The platform, formerly known as Melon, focuses on asset management and cryptocurrency portfolio management. Users can create, manage, and share their own investment funds on Enzyme without intermediaries like banks or fund managers. Enzyme uses smart contracts to ensure transparent, secure, and cost-effective investments. The cryptocurrency of the Enzyme network is MLN.

How does Enzyme work?

Enzyme functions as a decentralized trading protocol built on the Ethereum blockchain. It allows users to independently create, manage, and share their investment funds. Enzyme operates as follows:

• Users create a fund: Through Enzyme, participants can create their investment funds and implement custom investment strategies.
• Liquidity pooling: Users can combine their assets in a pool, providing more capital for investments and more trading opportunities.
• Smart contracts enable transparent, secure, and cost-effective investments. They are used for fund management, executing transactions, and setting rules and conditions.
• Governance: Enzyme is a decentralized autonomous organization (DAO), allowing the community to have a say in the project's development. MLN token holders can participate in the governance process and influence the platform's future.
• Users can invest in various crypto assets, including Bitcoin, Ethereum, and other ERC-20 tokens, as well as traditional assets like fiat currencies and gold.

The MLN token

The MLN token is designed to support the Enzyme platform and increase its token's value. MLN is used for governance, staking, and fees. It also has an annual inflation rate of 2%. This token economy encourages user participation and contributions while supporting the security and development of the platform and increasing the MLN token's value.

The Technology Behind MLN

The technology behind MLN aims to provide a decentralized trading protocol with high security, flexibility, and scalability. This includes the use of smart contracts, liquidity pooling, a modular architecture, off-chain oracles, and a decentralized autonomous organization (DAO). Smart contracts manage funds, execute transactions, and establish rules.

The liquidity pooling mechanism increases the available capital for investments, while the modular architecture allows users to implement custom investment strategies. Off-chain oracles provide real-time price information, and the DAO empowers users to influence the project's development and decision-making.

The Enzyme ecosystem

The Enzyme ecosystem consists of several components working together to provide a powerful decentralized trading protocol. These components include:

• The Enzyme Protocol: The core trading protocol using smart contracts on the Ethereum blockchain to facilitate cryptocurrency trading.
• The Enzyme Interface: The user interface granting participants access to the Enzyme protocol. It offers functionalities such as fund management, transaction execution, and portfolio viewing.
• The Enzyme DAO: The decentralized autonomous organization governing and managing the Enzyme protocol. MLN token holders can participate in decision-making and vote on important matters.
• Enzyme Modules: Optional modules enabling users to create their investment funds and implement custom investment strategies. Several modules are available, including Liquidity, Trading, Risk Management, and more.
• Integrations with other DeFi protocols and projects, including Aave, Curve, Compound, and Yearn Finance. This allows Enzyme users to benefit from the functionalities of these protocols.

Benefits of Enzyme

What benefits does Enzyme offer to its users and investors?

• Low transaction costs
• Fast transactions
• International payments
• Minimal paperwork
• High liquidity on the platform

Drawbacks of Enzyme

What drawbacks should investors in this token consider?

• High price volatility
• Limited acceptance as a payment method
• Relatively limited platform applications

Who is the founder of Enzyme?

The founders of Enzyme Finance and Melon are mathematician Rito Trinkler and Mona El Isa. Mona El Isa is a former vice president of Goldman Sachs. The company is based in Switzerland and conducted an initial coin offering in 2017.

Price forecasts

In 2027 experts expect a minimal price of €13.923 and a minimal price of €29.431 in 2032.